Evidence map›Paper›PMID 32366373›Full record

ArticleBiology open2020

A novel and cost-effective

Akash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, David Z Ivancic, Rashidra R Walker, Jankiben R Patel, Karen M Gallegos, A Michael Davidson, Seema A Khan, Rajendra G Mehta and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Akash GuptaDepartment of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Geetanjali GuptaDepartment of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Rajeshwari R MehtaCancer Biology Division, IIT Research Institute, Chicago, IL 60616, USA.
David Z IvancicDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Rashidra R WalkerDivision of Basic Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Jankiben R PatelDivision of Basic Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Karen M GallegosDivision of Basic Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
A Michael DavidsonDivision of Basic Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
Seema A KhanDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Rajendra G MehtaCancer Biology Division, IIT Research Institute, Chicago, IL 60616, USA.
Syreeta L TilghmanDivision of Basic Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA syreeta.tilghman@famu.edu.ORCID 0000-0003-3215-1252
Florida Agricultural and Mechanical University · USIIT Research Institute · USNorthwestern University · USUniversity of Arizona · US

Funding

Second line breast cancer therapy alters aromatase inhibitor resistant metastasisSC1GM125617 · NIGMS · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI TILGHMAN, SYREETA L · 2018 to 2021
$1.5M
NIGMS NIH HHS SC1 GM125617
6 · The paper itself

Abstract

Mouse mammary organ culture (MMOC) is used to evaluate the efficacy of chemopreventive agents against the development of carcinogen-induced preneoplastic lesions and is highly correlative to

Indexed as

Disease Models, AnimalAnimalsAntioxidant Response ElementsBiomarkers, TumorBreast NeoplasmsCell Line, TumorCells, CulturedCost-Benefit AnalysisDisease SusceptibilityFemaleHumansMammary Neoplasms, ExperimentalMiceOrgan Culture TechniquesPromoter Regions, GeneticXenograft Model Antitumor AssaysBiomarkers, TumorBreast cancer modelMammary glandOrgan cultureOrthotopic model

Identifiers

PMID32366373
PMCPMC7272353
OpenAlexW3023262964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.